The patented breakthrough technology of Brainsway unfolds a new dawn in depression treatment. It offers a clinically-proven solution for various categories of depression patients, ranging from mild to severe depression cases.

NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.

Depression is a serious medical illness affecting more than 14 million American adults every year. Brainsway Deep TMS, an effective noninvasive therapy, can bring new hope for long-standing drug-resistant depression.

NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.